Global Bone Grafts and Substitutes (BGS) Market Research Report 2022

Bone grafts and substitutes (BGS) comprise the products that are used for the replacement of missing bones or to repair bone fractures. BGS are widely used in hip, foot and ankle surgeries, fractures and bone injuries. Bone graft and substitutes usually include components like osteoconductive matrix that act as scaffold for the development of new bone, osteoinductive proteins that supports mitogenesis of identical bone cells and osteogenic cells which are capable of forming bone in the appropriate environment. Bone grafts may be allografts, autologus or synthetic types. Main objective behind the use of bone graft and substitute product is to gain healing from factures and bone injuries or to replace the natural bone.
Due to the COVID-19 pandemic, the global Bone Grafts and Substitutes (BGS) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Bone Grafts and Substitutes (BGS) market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Bone Grafts and Substitutes (BGS) landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Increasing cases of orthopaedic surgeries and musculoskeletal disorders (MSD) which demands the use of bone grafts and substitutes will drive the growth of the market. For example, according to American Academy of Orthopaedic Surgeons, approximately 3 million musculoskeletal procedures perform annually in the United States. In addition, it is also stated that bone grafts are used in around 2.2 million orthopaedic procedures globally. Thus, increasing use of bone grafts coupled with increasing cases of disorders that demands use of these materials will boost the growth of bone grafts and substitutes market. Furthermore, many key players offer variety of bone graft products that will attract more number of customers and hence drives the market growth. For example, Synthes, Inc., a Johnson and Johnson Company offers chronOS Strip bone graft substitute. This synthetic bone graft is manufactured from chronOS β-tricalcium phosphate granules that can be perfuse with patients own bone marrow and blood. Additionally, consistent efforts of many key players of this market to develop biodegradable composite structures and polymeric materials will attract customers to use bone grafts and substitute products and hence drives the market growth. Various other factors like advancement in technologies and increasing number of mergers and acquisitions will also drive the market growth of bone grafts and substitutes. However, some of the limitations using bone grafts and substitutes like donor site morbidity and difficulty in supplying these materials will hinder the market growth of bone grafts and substitutes.
This report focuses on Bone Grafts and Substitutes (BGS) volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Bone Grafts and Substitutes (BGS) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Bone Grafts and Substitutes (BGS) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Ceramic-Based BGS
Polymer-Based BGS
Growth Factor-Based BGS
Cell-Based BGS
Harvested BGS
Others
Segment by Application
Spinal Fusion
Dental
Joint Reconstruction
Craniomaxillofacial
Foot and Ankle
Long Bone
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Medtronic
Wright Medical Technology
Synthes
Stryker
Baxter International
TiGenix
Integra LifeSciences Corporation

Frequently Asked Questions